EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Adr1 transcription factor directs regulation of the ergosterol pathway and azole resistance in Candida albicans

Manjari Shrivastava iD, Gaëlle S Kouyoumdjian, Eftyhios Kirbizakis, Daniel Ruiz, Manon Henry iD, Antony T Vincent, Adnane Sellam, Malcolm Whiteway iD

mBio · 31.10.2023 · 14 (5)

DOI: 10.1128/mbio.01807-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 31.10.2023. Verfasst von Manjari Shrivastava und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Concordia University , Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Candida albicans, Transcription Factors. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), FRQ | Fonds de Recherche du Québec-Santé (FRQS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcription factors (TFs) play key roles in cellular regulation and are critical in the control of drug resistance in the fungal pathogen Candida albicans . We found that activation of the transcription factor C4_02500C_A (Adr1) conferred significant resistance against fluconazole. In Saccharomyces cerevisiae , Adr1 is a carbon-source-responsive zinc-finger transcription factor required for transcription of the glucose-repressed gene ADH1 and of genes required for ethanol, glycerol, and fatty acid utilization. Motif scanning of promoter elements suggests that Adr1 may be rewired in fungi and govern the ergosterol synthesis pathway in C. albicans . Because previous studies have identified the zinc-cluster transcription factor Upc2 as a regulator of the ergosterol pathway in both fungi, we examined the relationship between Adr1 and Upc2 in sterol biosynthesis in C. albicans . Phenotypic profiles of either ADR1 or UPC2 modulation in C. albicans showed differential growth in the presence of fluconazole; either adr1 or upc2 homozygous deletion results in sensitivity to the drug, while their activation generates a fluconazole-resistant strain. The rewiring from ergosterol synthesis to fatty acid metabolism involved all members of the Adr1 regulon except the alcohol dehydrogenase Adh1, which remains under Adr1 control in both circuits and may have been driven by the lifestyle of S . cerevisiae , which requires the ability to both tolerate and process high concentrations of ethanol. Importance Research often relies on well-studied orthologs within related species, with researchers using a well-studied gene or protein to allow prediction of the function of the ortholog. In the opportunistic pathogen Candida albicans , orthologs are usually compared with Saccharomyces cerevisiae , and this approach has been very fruitful. Many transcription factors (TFs) do similar jobs in the two species, but many do not, and typically changes in function are driven not by modifications in the structures of the TFs themselves but in the connections between the transcription factors and their regulated genes. This strategy of changing TF function has been termed transcription factor rewiring. In this study, we specifically looked for rewired transcription factors, or Candida -specific TFs, that might play a role in drug resistance. We investigated 30 transcription factors that were potentially rewired or were specific to the Candida clade. We found that the Adr1 transcription factor conferred resistance to drugs like fluconazole, amphotericin B, and terbinafine when activated. Adr1 is known for fatty acid and glycerol utilization in Saccharomyces , but our study reveals that it has been rewired and is connected to ergosterol biosynthesis in Candida albicans .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida albicansTranscription FactorsAntifungal AgentsAzolesErgosterolFluconazoleCandidaSaccharomyces cerevisiaeDrug Resistance, FungalMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Adr1Candida albicansalcohol and fatty acid metabolismergosterolrewiring

Substanzen

Transcription FactorsAntifungal AgentsAzolesErgosterolFluconazole

Autor:innen und Institutionen

  • Department of Biology, Concordia University , Montréal, Quebec, Canada.
  • Center for research, Montreal Heart Institute , Montréal, Quebec, Canada.
  • Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Université de Montréal , Montréal, Quebec, Canada.
  • Department of Animal Sciences, Université Laval , Quebec City, Canada.

ORCID-Profile: Manjari Shrivastava, Manon Henry, Malcolm Whiteway

Förderung

  • Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
  • FRQ | Fonds de Recherche du Québec-Santé (FRQS)

Zitieren

APA

Shrivastava, M., Kouyoumdjian, G. S., Kirbizakis, E., Ruiz, D., Henry, M., Vincent, A. T., Sellam, A., & Whiteway, M. (2023). The Adr1 transcription factor directs regulation of the ergosterol pathway and azole resistance in Candida albicans. mBio, 14(5). https://doi.org/10.1128/mbio.01807-23

Vancouver

Shrivastava M, Kouyoumdjian GS, Kirbizakis E, Ruiz D, Henry M, Vincent AT, et al. The Adr1 transcription factor directs regulation of the ergosterol pathway and azole resistance in Candida albicans. mBio. 2023;14(5). doi:10.1128/mbio.01807-23

BibTeX
@article{Shrivastava2023,
  author = {Shrivastava, Manjari and Kouyoumdjian, Gaëlle S and Kirbizakis, Eftyhios and Ruiz, Daniel and Henry, Manon and Vincent, Antony T and Sellam, Adnane and Whiteway, Malcolm},
  title = {The Adr1 transcription factor directs regulation of the ergosterol pathway and azole resistance in Candida albicans},
  journal = {mBio},
  year = {2023},
  volume = {14},
  number = {5},
  doi = {10.1128/mbio.01807-23}
}
Kostenlos starten →